A leading fantasy sports and sports betting company has been honored with the Heavy Hitter award from Benzinga at its first-ever Titans Sports Betting conference.
What’s A Heavy Hitter?
Gainers
TScan Therapeutics, Inc. (NASDAQ: TCRX) shares gained 118% to $4.68 after the company and Amgen announced collaboration to identify novel targets in Crohn's disease.
Financial Outlook
Genius expects to generate Group Revenue of approximately $400 million and Group Adjusted EBITDA of approximately $49 million in 2023. The Company is also maintaining its expectation to generate